All lobbying filings

Blount Strategic Initiatives

Blount Strategic Initiatives filed a Q2 report for Myriad Genetics, Inc. on July 3, 2026, reporting $10,000 in lobbying income.

Lobbying for Myriad Genetics, Inc. · Myriad is a genetic testing and precision medicine company.

As filed: BLOUNT STRATEGIC INITIATIVES for MYRIAD GENETICS, INC.

All filings by Blount Strategic Initiatives · Everything Myriad Genetics, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 3, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Veterans

Issues relating to veterans' depression and the Genesight product.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.